METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease—protocol for a multicentre, non-randomised, single-arm, prospective study

METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease—protocol for a multicentre, non-randomised, single-arm, prospective study

<strong>Introduction </strong>Crohn’s disease (CD) is characterised by discontinuous, relapsing enteric inflammation. Instituting advanced therapies at an early stage to suppress inflammation aims to prevent future complications such as stricturing or penetrating disease, and subsequent...

Bibliografiset tiedot
Päätekijät:	Kumar, S, Plumb, A, Mallett, S, Bhatnagar, G, Bloom, S, Clarke, CS, Hamlin, J, Hart, AL, Jacobs, I, Travis, S, Vega, R, Halligan, S, Taylor, SA
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	BMJ Publishing Group 2022

Samankaltaisia teoksia

Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial
Tekijä: Taylor, SA, et al.
Julkaistu: (2018)

Diagnostic performance of magnetic resonance enterography disease activity indices compared with a histological reference standard for adult terminal ileal Crohn’s disease: experience from the METRIC trial
Tekijä: Kumar, S, et al.
Julkaistu: (2022)

METRIC (MREnterography or ulTRasound in Crohn’s disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over
Tekijä: Taylor, S, et al.
Julkaistu: (2014)

Crohn’s disease or Crohn’s diseases?
Tekijä: Arnott, IDR, et al.
Julkaistu: (2003)

Medical management of Crohn's disease.
Tekijä: Cummings, JR, et al.
Julkaistu: (2008)

Interfering with leukocyte trafficking in Crohn's disease
Tekijä: Biswas, S, et al.
Julkaistu: (2019)

Mortality in patients hospitalised with Crohn's disease.
Tekijä: Siffledeen, J, et al.
Julkaistu: (2012)

The experience of being newly diagnosed with Parkinson's Disease: an interpretative phenomenological analysis
Tekijä: Green, Alice E.
Julkaistu: (2007)

Is Crohn's disease a rightly used eponym?
Tekijä: Van Hootegem, P, et al.
Julkaistu: (2019)

Smoking status in therapeutic trials in Crohn's disease.
Tekijä: McGovern, D, et al.
Julkaistu: (2005)

Crohn's disease and pregnancy.
Tekijä: Khosla, R, et al.
Julkaistu: (1984)

Perianal Crohn's disease.
Tekijä: Singh, B, et al.
Julkaistu: (2004)

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Tekijä: Colombel, J, et al.
Julkaistu: (2017)

Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn's disease
Tekijä: Goodday, SM, et al.
Julkaistu: (2021)

Review article: insurance risks for patients with ulcerative colitis or Crohn's disease.
Tekijä: Travis, S
Julkaistu: (1997)

Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
Tekijä: Mowat, C, et al.
Julkaistu: (2016)

Immunosuppression for management of Crohn's disease
Tekijä: Milosevic, I, et al.
Julkaistu: (2016)

Field Cancerization in Crohn's Disease
Tekijä: Graham, T, et al.
Julkaistu: (2010)

CTSH regulates : cell function and disease progression in newly diagnosed type 1 diabetes patients
Tekijä: Reinheckel, Thomas, et al.
Julkaistu: (2014)

Evidence for separate disease phenotypes in intestinal Crohn's disease.
Tekijä: Borley, N, et al.
Julkaistu: (2002)

Are measures of adiposity associated independently with incident cardiovascular disease in individuals with newly diagnosed type 2 diabetes?
Tekijä: Coleman, R, et al.
Julkaistu: (2007)

10-minute consultation. Newly diagnosed hypertension.
Tekijä: A'Court, C
Julkaistu: (2002)

Autoantibodies in people with newly diagnosed focal epilepsy
Tekijä: McGinty, R, et al.
Julkaistu: (2017)

NOD2 function in Crohn's disease.
Tekijä: Simmons, A
Julkaistu: (2011)

Treatment of Crohn's disease--the new era.
Tekijä: Jewell, D
Julkaistu: (2002)

Prevention of postoperative recurrence of Crohn's disease.
Tekijä: van Loo, E, et al.
Julkaistu: (2012)

NOD2 SIGNALLING IN CROHN'S DISEASE
Tekijä: Allan, P, et al.
Julkaistu: (2011)

Yersinia colitis associated with Crohn's disease.
Tekijä: Treacher, D, et al.
Julkaistu: (1985)

Endocrine dysfunction in children with Crohn's disease.
Tekijä: Chong, S, et al.
Julkaistu: (1984)

Prevention of postoperative recurrence of Crohn's disease
Tekijä: Van Loo, E, et al.
Julkaistu: (2012)

Pathogenesis of Crohn's disease: the environment revisited.
Tekijä: Jewell, D
Julkaistu: (1995)

Crohn's disease: Genes, viruses and microbes.
Tekijä: Simmons, A
Julkaistu: (2010)

Preventing postoperative recurrence of Crohn's disease.
Tekijä: Borley, N, et al.
Julkaistu: (1997)

Comparison between prospective and retrospective evaluation of Crohn's disease activity index.
Tekijä: Frenz, M, et al.
Julkaistu: (2005)

Impact of interobserver disagreement on phenotype-genotype associations in Crohn's disease.
Tekijä: Oefferlbauer-Ernst, A, et al.
Julkaistu: (2007)

BIOCHEMICAL RISK-FACTORS FOR CARDIOVASCULAR-DISEASE IN NEWLY-DIAGNOSED TYPE-II DIABETIC-PATIENTS AND AGE-MATCHED SUBJECTS
Tekijä: Turner, R, et al.
Julkaistu: (1993)

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
Tekijä: D'Haens, G, et al.
Julkaistu: (2009)

Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review.
Tekijä: Cassinotti, A, et al.
Julkaistu: (2009)

Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery.
Tekijä: Tzivanakis, A, et al.
Julkaistu: (2012)

Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Tekijä: Hyder, SA, et al.
Julkaistu: (2006)